VERRUCIFORM EPIDERMODYSPLASIA (STUDY OF 2 CASES) IN CHU MOHAMED V MARRAKECH MORROCCO.
- Department of Plastic and Reconstructive Surgery in CHU Mohamed VI, Marrakech, Morocco.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Verruciform epidermodysplasia (VE) or Lutz-Lewandowski disease is a rare genodermatosis, most often autosomal recessive, characterized by abnormal susceptibility to infection by certain types of HPV. We report 2 cases with malignant transformation in squamous cell and basocellular carcinomas. We study 2 cases of patients aged of 50 and 34 years old that suffer from this illness and have been received in plastic restorative and burns Department in CHU Mohamed V Marrakech Morocco. In our study we try to focus on the origin, factors and the diagnostic of the Verruciform epidermodysplasia and compare them to those evocated by other authors and the treatment that has been followed. Verruciform epidermodysplasia is a rare disease that requires early diagnosis to avoid the high potential for transformation for these patients.
- Ortak T, Uysal C A, AlagosMS,Orbay H, Sensoz O. Epidermodysplasia Verruciformis : An Unusual Presentation.
- Dermatol Surg 2006 ; 32 : 302-6
- Micalli G, Nasca MR, Dall?oglio F, Musumeci ML. Cimetine therapy for epidermodysplasia verruciformis. J Am Acad
- Dermatol 2003 ; 48 : 9-10.
- Weber BP, Fierlbeck G, Kempf HG. Multiple metachronous skin squamous cell carcinomas and epidermodysplasia
- verruciformis in the head region : a human papillomavirusassociated disease. Eur Arch Otorhinolaryngol 1994 ;
- DEGOS R .DermatologieEd. Med. Flammarion, Paris, 1981.
- DESCAMPS V., BLANCHET-BARDON C., PETIT A., BACCARD M.,FISHER A., DUBERTRET L.
- Epidermodysplasie verruciforme apr?s greffe de moelle pour letraitement d'un d?ficit immunitaire combin? s?v?re : un mod?le pourcomprendre le d?ficit immunitaire sp?cifique de l'E.V. ?Ann. Derm. V?n?reol., 1991, 118, 847-850.
- 44- MATHIEU A., AVRIL M-F., DUVILLARD P., BLANCHET-BARDONC., ORTH G., BANANGER C., BOGNEL C., CHARPENTIER M.,GIRINSKY M.,PRADE M., LUBOINSKI B.Epidermodysplasie verruciforme et papillomavirus Pr?sence d'HPV 5 dans une m?tastase ganglionnaire.Ann. Dermatol. V?n?r?ol., 1985, 112 : 741-742
- 50- PFISTER H.Human papillomavirus and impaired immunity epidermodysplasia
- Verrucifonnis Arch. Derm. , 1987, 123 : 1469-1470
- JABLONSKA S., OBALEK S., ORTH G., HAFTEK M.,CHORZELSKA M.J.
- Regression of the lesions of epidermodysplasia verruciformis .Brit. J. Denn. 1982, 107 : 109-116
- ,BOURLONDA.,MONTEIROB.,AMOUSSOUGNENOUD.,GNINAFON M., YEDOMON H., Epidennodysplasie verrucifonne : difficult?s diagnostiques chez un sujetde race noire. Ann. Denn. V?n?r?al.. 1990. 117 : 957-958.
- CIVATTE J.Histopathologie cutan?e. Ed. Med. Flammarion, Paris, 1967. 293
- LEDERMAN D.P.Epidem10dysplasie verrucifom1e de Lewandowsky-Lutz. affection virale mod?le de recherche sur l'action des virus ? potentiel oncog?ne?;Med. et Hyg., 1981, 39 : 1576-1582.
- DEGOS R., LEFORT P., BATISTA A.Epidermodysplasie verruciforme de Lewandowsky-LutzBull. Soc. Fr. Derm. Syph. 1957, 64 : 278-279.
- JABLONSKA S., ORTH G.,Epiderrnodysplasia verruciforrnis.Clin. Derrn. 1980, 3 : 83-86
- Lane JA, Bowman PH, Cohen DJ. Epidermodysplasia verruciformis. South Med J 2003 ; 96 : 613-5
- Anadolu R, Oskay T, Erdem C, Boyvat A, Terzi E, G?rgey E.Treatment of epidermodysplasia verruciformis with acombination of acitretin and interferon alfa-2a. J Am Acad.Dermatol 2001 ; 45 : 296-9.
- Junko Hi, Chihiro M, Tsuyoshi M, Makoto K,, Masaaki M.Treatment of localized epidermodysplasia verruciformis witht acalcitol ointment. Internat J Dermatology 2002 ; 41 : 817?20.
[Ouafaa Dhaidah, Moulay Driss Elamrani, Yassine Benchamkha and Salwa Ettalbi. (2018); VERRUCIFORM EPIDERMODYSPLASIA (STUDY OF 2 CASES) IN CHU MOHAMED V MARRAKECH MORROCCO. Int. J. of Adv. Res. 6 (Jan). 632-635] (ISSN 2320-5407). www.journalijar.com
CHU Mohamed V Marrakech Morocco
